Cerebral amyloid angiopathy-related microbleeds and cerebrospinal fluid biomarkers in Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 55, Issue 3, 2017, Pages 905-913

  Noguchi Shinohara, Moeko ^a   Komatsu, Junji ^a   Samuraki, Miharu ^a   Matsunari, Ichiro ^b,c   Ikeda, Tokuhei ^a   Sakai, Kenji ^a   Hamaguchi, Tsuyoshi ^a   Ono, Kenjiro ^a,d   Nakamura, Hiroyuki ^a   Yamada, Masahito ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b Medical and Pharmacological Research Center Foundation   (Japan)

^c SAITAMA MEDICAL UNIVERSITY HOSPITAL   (Japan)

^d SHOWA UNIVERSITY   (Japan)

Author keywords

Alzheimer's disease; biomarkers; cerebral amyloid angiopathy; cerebrospinal fluid

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; APOLIPOPROTEIN E2; APOLIPOPROTEIN E4; BIOLOGICAL MARKER; TAU PROTEIN; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); APOLIPOPROTEIN E; PEPTIDE FRAGMENT;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN CORTEX; BRAIN HEMORRHAGE; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; GROUPS BY AGE; HUMAN; LEUKOARAIOSIS; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN PHOSPHORYLATION; RISK FACTOR; SEX DIFFERENCE; SUBCORTEX; VASCULAR AMYLOIDOSIS; CEREBROSPINAL FLUID; COMPLICATION; DIAGNOSTIC IMAGING; GENETICS; MENTAL HEALTH; MIDDLE AGED; RETROSPECTIVE STUDY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; APOLIPOPROTEINS E; CEREBRAL AMYLOID ANGIOPATHY; FEMALE; HUMANS; INTRACRANIAL HEMORRHAGES; LEUKOARAIOSIS; MAGNETIC RESONANCE IMAGING; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PEPTIDE FRAGMENTS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 85005950895     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-160651     Document Type: Article

References (30)

1. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. (1984) Clinical diagnosis of Alzheimer?s disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer?s Disease. Neurology 34, 939-944.
2. Matsubara E, Kanai M, Watanabe M, Nakamura T, Tomidokoro Y, Wakabayashi K, Igeta Y, Ikeda Y, Mizusawa K, Amari M, Ishiguro K, Kawarabayashi T, Harigaya Y, Okamoto K, Hirai S. (1998) Combination assay of CSF Tau, A-1-40 and A-1-42. (43) as a biochemical marker of Alzheimer?s disease. J Neurol Sci 158, 134-140.
3. Attems J. (2005) Sporadic cerebral amyloid angiopathy: Pathology, clinical implications, and possible pathomechanisms. Acta Neuropathol 110, 345-359.
4. Yamada M. (2015) Cerebral amyloid angiopathy: Emerging concepts. J Stroke 17, 17-30.
5. Prelli F, Castano E, Glenner GG, Frangione B. (1988) Differences between vascular and plaque core amyloid in Alzheimer?s disease. J Neurochem 51, 648-651.
6. Suzuki N, Iwatsubo T, Odaka A, Ishibashi Y, Kitada C, Ihara Y. (1994) High tissue content of soluble-1-40 is linked to cerebral amyloid angiopathy. Am J Pathol 145, 452-460.
7. Verbeek MM, Kremer BP, Rikkert MO, Van Domburg PH. Skehan ME, Greenberg SM. (2009) Cerebrospinal fluid amyloid beta. (40) is decreased in cerebral amyloid angiopathy. Ann Neurol 66, 245-249.
8. Renard D, Castelnovo G, Wacongne A, Le Floch A, Thouvenot E, Mas J, Gabelle A, Labauge P, Lehmann S. (2012) Interest of CSF biomarker analysis in possible cerebral amyloid angiopathy cases defined by the modified Boston criteria. J Neurol 259, 2429-2433.
9. Park J-H, Seo SW, Kim C, Kim GH, Noh HJ, Kim ST, Kwak KC, Yoon U, Lee JM, Shin JS, Kim CH, Noh Y, Cho H, Kim HJ, Yoon CW, Oh SJ, Kim JS, Choe YS, Lee KH, Lee JH, Ewers M, Weiner MW, Werring DJ, Na DL. (2013) Pathogenesis of cerebral microbleeds: In vivo imaging of amyloid and subcortical ischemic small vessel disease in 226 individuals with cognitive impairment. Ann Neurol 73, 484-593.
10. Chiang GC, Hernandez C, Kantarci K, Jack CR Jr, Weiner MW, for the Alzheimer?s Disease Neuroimaging Initiative. (2015) Cerebral microbleeds, CSF p-Tau, and cognitive decline: Significance of anatomic distribution. Am J Neuroradiol 36, 1635-1641.
11. Hesse C, Rosengren L, Andreasen N, Davidsson P, Vanderstichele H, Vanmechelen E, Blennow K. (2001) Transient increase in total tau but not phosphor-Tau in human cerebrospinal fluid after acute stroke. Neurosci Lett 297, 187-190.
12. Knudsen KA, Rosand J, Karluk D, Greenberg SM. (2011) Clinical diagnosis of cerebral amyloid angiopathhy: Validation of the Boston criteria. Neurology 56, 537-539.
13. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. (1982) A new clinical scale for the staging of dementia. Br J Psychiatry 140, 566-572.
14. Folstein MF, Folstein SE, McHugh PR. (1975) Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12, 189-198.
15. Wechsler D. (1987) Wechsler Memory Scale: Revised, The Psychological Corporation, San Antonio.
16. Kamboh MI, Ferrel RE, Kottke B. (1998) Genetic studies of human apolipoproteinsV:Anovel rapid procedure to screen apolipoprotein E polymorphism. J Lipid Res 29, 1535-1543.
17. Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, Lindley RI, O?Brien JT, Barkhof F, Benavente OR, Black SE, Brayne C, Breteler M, Chabriat H, Decarli C, de Leeuw FE, Doubal F, Duering M, Fox NC, Greenberg S, Hachinski V, Kilimann I, Mok V, Oostenbrugge Rv, Pantoni L, Speck O, Stephan BC, Teipel S, Viswanathan A, Werring D, Chen C, Smith C, van Buchem M, Norrving N, Gorelick PB, Dichgans M, STandards for ReportIng Vascular changes on nEuuroimaging. (STRIVE v1). (2013) Standards for reporting vascular changes on neuroimaging. (STRIVE, v1) Neuroimaging standards for research into small vessel disease and its contribution to aging and neurodegeneration. Lancet Neurol 12, 822-838.
18. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. (1987) MR signal abnormalities at 1.5T in Alzheimer?s dementia and normal aging. Am J Roentgenol 149, 351-356.
19. Schisterman EF, Perkins NJ, Liu A, Bondell H. (2005) Optimal cut-point and its corresponding Youden Index to discriminate individuals using pooled blood samples. Epidemiology 16, 73-81.
20. Goos JD, Teunissen CE, Veerhuis R, Verwey NA, Barkhof F, Blankenstein MA, Scheltens P, van der Flier WM. (2012) Microbleeds relate to altered amyloid-beta metabolism in Alzheimer?s disease. Neurobiol Aging 1011, e1-1011.e9.
21. Kester M, Goos JD, Teunissen CE, Benedictus MR, Bouman FH, Wattjes MP, Barkhof F, Scheltens P, van der Flier WM. (2014) Associations between cerebral small-vessel disease and Alzheimer disease pathology as measured by cerebrospinal fluid biomarkers. JAMA Neurol 71, 855-862.
22. van der Vies AE, Goos JD, Barkhof F, Scheltens P, van der Fier WM. (2012) Microbleeds do not affect rate of cognitive decline in Alzheimer?s disease. Neurology 79, 763-769.
23. Benedictus MR, Prins ND, Goos JD, Scheltens P, Barkhof F, van der Fier WM. (2015) Microbleeds, mortality, and stroke in Alzheimer?s disease: TheMISTRALStudy. JAMANeurol 72, 539-545.
24. Goos JD, Kester MI, Barkhof F, Klein M, Blankenstein MA, Scheltens P, van der Flier WM. (2009) Patients with Alzheimer disease with multiple microbleeds relation with cerebrospinal fluid biomarkers and cognition. Stroke 40, 3455-3460.
25. Chiang GC, Hernandez C, Kantarci K, JackJr. CR, Weiner MW, for the Alzheimer?s Disease Neuroimaging Initiative. (2015) Cerebral microbleeds, CSF p-Tau, and cognitive decline: Significance of anatomic distribution. Am J Neuroradiol 36, 1635-1641.
26. Hanyu H, Tanaka Y, Shimizu S, Takasaki M, Abe K. (2003) Cerebral microbleeds in Alzheimer?s disease. J Neurol 250, 1496-1497.
27. Nakata-Kudo Y, Mizuno T, Yamada K, Shiga K, Yoshikawa K, Mori S, Nishimura T, Nakajima K, Nakagawa M. (2006) Microbleeds in Alzheimer disease are more related to cerebral amyloid angiopathy than cerebrovascular disease. Dement Griatr Cogn Disord 22, 8-14.
28. Cordonnier C, van der Fier WM, Sluimer JD, Leys D, Barkhof F, Scheltens P. (2006) Prevalence and severity of microbleeds in a memory clinic setting. Neurology 66, 1356-1360.
29. Cordonnier C, Al-Shahi Salman R, Wardlaw J. (2007) Spontaneous brain microbleeds: Systematic review, subgroup analyses and standards for study design and reporting. Brain 130, 1988-2003.
30. Pettersen JA, Sathiyamoorthy G, Gao FQ, Szilaqyi G, Nadkarmi NK, St George-Hyslop P, Rogaeva E, Black SE. (2008) Microbleed topography, leukoaraiosis, and cognition in probable Alzheimer disease from the Sunnybrook dementia study. Arch Neurol 65, 790-795.